Current concepts of organ preservation in head and neck cancer

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 4, 2011, Pages 481-487

  Wang, C J ^a   Knecht, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Concurrent radio chemotherapy; Head and neck cancer; Induction chemotherapy; Molecular therapy; Organ preservation; Organ preservation surgery

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CETUXIMAB; CISPLATIN; CREATININE; DOCETAXEL; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEFITINIB; HYDROXYUREA; TAXANE DERIVATIVE;

BIOLOGICAL THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; ENDOSCOPIC SURGERY; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CANCER; HYPOPHARYNX CARCINOMA; LARYNGECTOMY; LARYNX CANCER; LARYNX CARCINOMA; MOLECULARLY TARGETED THERAPY; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CANCER; NEUTROPENIA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; HEAD AND NECK NEOPLASMS; HUMANS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 79955941839     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-010-1407-8     Document Type: Review

References (50)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225-249
2. Robert Koch-Institut GdeKiDeV (ed) (2010) Krebs in Deutschland 2005/2006 - Häufigkeiten und Trends. 7 ed. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V.
3. Holsinger FC (2008) Swing of the pendulum: optimizing functional outcomes in larynx cancer. Curr Oncol Rep 10(2):170-175
4. Lefebvre JL (1998) Larynx preservation: the discussion is not closed. Otolaryngol Head Neck Surg 118(3 Pt 1):389-393
5. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949-955
6. Pignon JP, le Maitre A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69(2 Suppl):S112-S114 (Pubitemid 47369400)
7. Wolf GTHW, Gross Fisher S (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer (The Department of Veterans Affairs [VA] Laryngeal Cancer Study Group). N Engl J Med 324:1685-1690
8. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091-2098 (Pubitemid 37464533)
9. Olsen KD (2010) Reexamining the treatment of advanced laryngeal cancer. Head Neck 32(1):1-7
10. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88(13):890-899 (Pubitemid 26230640)
11. Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D et al (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34(3):224-228 (Pubitemid 28267175)
12. Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B, Trotti A et al. (2006) Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx - induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. ASCO Meeting Abstracts 24(18 Suppl):5517
13. Trotti A, Pajak TF, Gwede CK, Paulus R, Cooper J, Forastiere A et al (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8(7):613-624 (Pubitemid 46995620)
14. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L et al (2009) Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101(3):142-152
15. Adelstein DJ, Rodriguez CP (2008) Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 35(3):211-220 (Pubitemid 351787694)
16. Forastiere AA (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol 97(8):701-707
17. Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H et al (2007) Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 25(25):3971-3977 (Pubitemid 47477276)
18. Biete Sola A, Marruecos Querol J, Calvo Manuel FA, Verger Fransoy E, Rovirosa Casino A, Grau de Castro JJ et al (2007) Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. Clin Transl Oncol 9(4):244-250
19. Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA et al (2001) Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol 12(3):343-347 (Pubitemid 32288690)
20. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101(7):498-506
21. Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW et al (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20(5):921-927
22. Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker L, Sarlis NJ et al. (2010) Oropharynx cancer (OPC) in TAX 324: Human papillomavirus (HPV) and survival. ASCO Meeting Abstracts 28(15 Suppl):5525
23. Lorch JH, Posner MR, Goloubeva O, Cullen KJ, Sarlis NJ, Tishler RB et al. (2010) Long-term results from TAX324: a phase III trial of sequential therapy comparing TPF to PF in locally advanced (LA) squamous cell cancer of the head and neck (HNC). ASCO Meeting Abstracts 28(15 Suppl):5512
24. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17):1695-1704 (Pubitemid 350005151)
25. Goodwin WJ Jr (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl 93):1-18
26. Pomerantz RG, Grandis JR (2004) The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 31(6):734-743 (Pubitemid 39602679)
27. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567-578 (Pubitemid 43209104)
28. Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O (2005) Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 114(4):314-322 (Pubitemid 40529988)
29. Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O (2004) Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 130(9):1092-1099
30. Tufano RP (2002) Organ preservation surgery for laryngeal cancer. Otolaryngol Clin North Am 35(5):1067-1080
31. Sheen TS, Ko JY, Chang YL (1998) Partial vertical laryngectomy in the treatment of early glottic cancer. Ann Otol Rhinol Laryngol 107(7):593-597
32. Yeager LB, Grillone GA (2005) Organ preservation surgery for intermediate size (T2 and T3) laryngeal cancer. Otolaryngol Clin North Am 38(1):11-20 vii
33. Wein RO, Weber RS (2005) The current role of vertical partial laryngectomy and open supraglottic laryngectomy. Curr Probl Cancer 29(4):201-214
34. Strong MS, Jako GJ (1972) Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol 81(6):791-798
35. Steiner W, Ambrosch P, Hess CF, Kron M (2001) Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 124(1):58-67 (Pubitemid 32096782)
36. Ambrosch P, Kron M, Steiner W (1998) Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107(8):680-688 (Pubitemid 28371389)
37. Steiner W, Fierek O, Ambrosch P, Hommerich CP, Kron M (2003) Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 129(1):36-43 (Pubitemid 36070874)
38. Ambrosch P (2007) The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15(2):82-88
39. O'Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG (2006) Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 116(8):1465-1472 (Pubitemid 44181466)
40. Weinstein GS, O'Malley BW Jr, Snyder W, Sherman E, Quon H (2007) Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 133(12):1220-1226 (Pubitemid 350294250)
41. Weinstein GS, O'Malley BW Jr, Snyder W, Hockstein NG (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116(1):19-23 (Pubitemid 46174121)
42. Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A (2009) Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266(9):1333-1352
43. Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31(6):748-758
44. Chen AY, Schrag N, Hao Y, Stewart A, Ward E (2007) Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope 117(1):16-21 (Pubitemid 46066056)
45. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl 111):1-13 (Pubitemid 44337830)
46. Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133(12):1270-1276 (Pubitemid 350294258)
47. Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C (2008) Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol 19(4):631-640
48. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P et al (2009) Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 21(6):1323-1360
49. Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22):3693-3704 (Pubitemid 46630546)
50. Beitler JJ, Cooper JS (2009) Seduction by induction? J Clin Oncol 27(1):9-10